Physician profile
Fred Lindsay
NPI 1750352316
$9,386.77
in general payments reported to CMS, 2019-2025
41 companies · $1,240 in 2025
The $1,240 reported for 2025 was more than what 83% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,183 · 2020: $482 · 2021: $1,379 · 2022: $1,657 · 2023: $1,839 · 2024: $1,607 · 2025: $1,240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,244 · Travel and Lodging: $242 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,244.42 |
| Travel and Lodging | $242.10 |
| Education | $198.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,478.78 | 2021-2025 | Inspire |
| Aerin Medical INC. | $1,115.22 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $961.17 | 2019-2025 | Xywav |
| Regeneron Healthcare Solutions, INC. | $905.69 | 2019-2025 | Dupixent |
| Glaxosmithkline, LLC. | $825.52 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Biocryst US Sales Co., LLC | $452.37 | 2021-2025 | Orladeyo |
| Intersect Ent, INC. | $402.63 | 2019-2022 | |
| Genzyme Corporation | $329.02 | 2019-2025 | |
| Acclarent, INC | $264.05 | 2019-2021 | |
| Tactile Systems Technology INC | $261.13 | 2024 | Entre Plus, Flexitouch Plus |
| Csl Behring | $253.51 | 2019-2024 | Haegarda, Hizentra |
| Stryker Corporation | $201.16 | 2019-2025 | Scopis Ent |
| Neurent Medical Limited | $199.13 | 2023-2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Olympus America INC. | $189.14 | 2019 | |
| Genentech USA, INC. | $186.75 | 2019-2025 | Xolair |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Lindsay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.